Key Transaction Details

Nephrocare Health Care Services, Philippines Inc., an overseas step-down wholly-owned subsidiary of Nephrocare Health Services Limited, has entered into an Asset Transfer Agreement dated October 27, 2026 with JCM Summit Health Inc. for the acquisition of identified assets relating to a dialysis center located at Don Mariano Marcos Avenue, Quezon City, Philippines.

Quantitative Information

The value of the Transaction exceeds the materiality threshold determined in accordance with the Company's Policy for Determination of Materiality of Events/Information. The specific consideration payable under the ATA is not disclosed as it constitutes confidential and commercially sensitive information, the disclosure of which may adversely affect the competitive position of the Company in the market.

Parties Involved

  • Purchaser: Nephrocare Health Care Services, Philippines Inc. (overseas step-down wholly-owned subsidiary of Nephrocare Health Services Limited)
  • Seller: JCM Summit Health Inc.

Purpose and Rationale

The purpose of entering into the agreement is the acquisition of dialysis center assets pursuant to the Asset Transfer Agreement, in accordance with and subject to the terms and conditions stipulated therein.

Relationship Between Parties

The Purchaser is an overseas step-down wholly-owned subsidiary of Nephrocare Health Services Limited. The Seller is not related to the promoter/promoter group/group companies of the Company in any manner.

Significant Terms

No special rights have been granted under the ATA (such as right to appoint directors, first right to share subscription, or right to restrict any change in capital structure).

Transaction Classification

The transaction does not fall within related party transactions and is not done at "arm's length" as it is not a related party transaction.

Additional Details

  • No share issuance involved in the transaction
  • No loan agreements involved
  • No nominee directors or potential conflicts of interest identified
  • No termination or amendment details applicable

The complete disclosure including Annexure I is available on the Company's website at www.nephroplus.com.